Bio News

The White House has announced the AI-based research acceleration initiative “Genesis Mission” and will invest more than $5 billion in 278 first-phase projects. The move follows an assessment that the number of new drug approvals and other measures have stagnated despite NIH funding more than doubling since the 1990s. Through the overhaul, the U.S. government will establish an AI-centered research and development system and accelerate the creation of groundbreaking scientific advances.

BIOBOOK TEAM
biobookmedia@biobook.co.krCosentyx Approved by FDA for 11th Indication: Polymyalgia Rheumatica
Delonix and Singapore’s A*STAR IDL to Collaborate on Vaccine Against Drug-Resistant Klebsiella pneumoniae
Brazilian Health Regulatory Agency Approves Oral Plaque Psoriasis Treatment Icotyde
Medtronic to Acquire Contego Medical for $380 Million
Brazilian Health Regulatory Agency Approves Botox for Masseter Muscle Prominence
Roche’s oral SERD Itovebi wins FDA approval, cutting risk of progression by 62%